Boaz Eimers
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Boaz Eimers has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Guofei Cui
Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California
53 shared publications - Joyce H. G. Lebbink
Department of Molecular Genetics, Oncode Institute, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3000 CA, Rotterdam, The Netherlands; Department of Radiotherapy, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3000 CA, Rotterdam, the Netherlands
53 shared publications - Kelly Schippers
Department of Gastroenterology and Hepatology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands
53 shared publications - Ling Wang
Department of Gastroenterology and Hepatology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands
53 shared publications - Maikel Petrus Peppelenbosch
Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands
53 shared publications - Marla Lavrijsen
Department of Gastroenterology and Hepatology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands
53 shared publications
Latest Publications
- Open Access
- 2 May 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling
The AXIN1 mutation landscape for various cancer types
- 2 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling
The AXIN1 mutation landscape for various cancer types
- Open Access
- 2 May 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 16 from Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling
Strong AXIN1 missense variants induce liver tumor formation in mice
- 2 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 16 from Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling
Strong AXIN1 missense variants induce liver tumor formation in mice
- Open Access
- 2 May 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 15 from Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling
Side-by-side comparison of selected AXIN1 variants in different domains
- 2 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 15 from Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling
Side-by-side comparison of selected AXIN1 variants in different domains
- Open Access
- 2 May 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 7 from Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling
Additional analysis of missense variants near the GSK3β domain
- 2 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 7 from Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling
Additional analysis of missense variants near the GSK3β domain
- Open Access
- 2 May 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 9 from Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling
AlphaFold structure prediction for human AXIN1
- 2 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 9 from Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling
AlphaFold structure prediction for human AXIN1
- Open Access
- 2 May 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling
Analysis of evolutionary conserved AXIN1 residues using the ConSurf tool.
- 2 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling
Analysis of evolutionary conserved AXIN1 residues using the ConSurf tool.
- Open Access
- 2 May 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling
Overview of the interactions at the interface between AXIN1 and β-catenin for the mutated amino acids and their predicted effects.
- 2 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling
Overview of the interactions at the interface between AXIN1 and β-catenin for the mutated amino acids and their predicted effects.
- Open Access
- 2 May 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 14 from Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling
Cartoon representation of AXIN1 with bound APC
- 2 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 14 from Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling
Cartoon representation of AXIN1 with bound APC